Cargando…
Cannabidiol (CBD) Consumption and Perceived Impact on Extrahepatic Symptoms in Patients with Autoimmune Hepatitis
BACKGROUND AND AIMS: Utilization and safety of cannabidiol (CBD) in patients with autoimmune hepatitis (AIH) are currently unknown. We aimed to identify the frequency of CBD use, impact on symptoms, and safety profile. METHODS: An invitation to complete a CBD-specific questionnaire was posted every...
Autores principales: | Mathur, Karan, Vuppalanchi, Vahin, Gelow, Kayla, Vuppalanchi, Raj, Lammert, Craig |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943405/ https://www.ncbi.nlm.nih.gov/pubmed/31363952 http://dx.doi.org/10.1007/s10620-019-05756-7 |
Ejemplares similares
-
Hepatic steatosis is highly prevalent but is not correlated with stiffness in autoimmune hepatitis
por: Chalasani, Sai, et al.
Publicado: (2020) -
Overlooked Symptoms in Autoimmune Hepatitis Negatively Impact Many Facets of Life
por: Jones, Emma, et al.
Publicado: (2022) -
Utilization and Impact of Complementary and Alternative Medicines in Symptomatic Autoimmune Hepatitis Patients
por: Gelow, Kayla, et al.
Publicado: (2021) -
Cannabidiol (CBD) in Cancer Management
por: O’Brien, Kylie
Publicado: (2022) -
Extrahepatic Autoimmune Diseases are Prevalent in Autoimmune Hepatitis Patients and Their First-Degree Relatives: Survey Study
por: Fogel, Rachel, et al.
Publicado: (2018)